Drug Manufacturers - Specialty & Generic | Healthcare
Ipca Laboratories Limited, a pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, CIS, and Australasia. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company also provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. It also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Market Cap
370458558464
Current Price
1460.2
52 Week Range
1168.2 - 1755.9
Previous Close
1466.7
Open
1470.0
Sector
Healthcare
Address
125, Kandivli Industrial Estate, Kandivli (West), Mumbai, 400067, India
Phone
+91-22621-05000
Fax
+91-22621-05439
Website
https://www.ipca.com
Day Low
1440.6
Day High
1470.0
Dividend Yield
0.27
PE Ratio
50.282368
Earnings Per Share
29.04
Beta
0.216
EBITDA
16667499520
Book Value
273.88
EPS
43.77272
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Premchand Godha A.C. A., B. Com., CA | Executive Chairman | 77 | 1947 |
Mr. Pranay Premchand Godha | CEO, MD & Executive Director | 52 | 1972 |
Mr. Ajit Kumar Bhanwarlal Jain A.C.A., B.Sc. | CFO, MD & Executive Director | 69 | 1955 |
Mr. Prashant Premchand Godha | Executive Director | 50 | 1974 |
Mr. Pawan Kothari | Vice President of Operations | 59 | 1965 |
Mr. Vishnu Saran Singh Kushwaha | Vice President of Technical | 56 | 1968 |
Mr. Harish Pandurang Kamath | Compliance Officer, Corporate Counsel & Company Secretary | 65 | 1959 |
Mr. Sunil Ghai | President of Marketing | 61 | 1963 |
Mr. Saidutta Nanda | President of Human Resources | - | - |
Dr. Ashok Kumar | President of R&D - Chemicals | 70 | 1954 |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.